NCT05953285

Brief Summary

This study aims to examine if partial sleep deprivation results in alterations blood markers and subjective markers of homeostatic, and hedonic appetite, as well as provide initial data as to the impact of sleep restriction on gastric emptying.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

July 15, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 20, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2024

Completed
Last Updated

December 15, 2023

Status Verified

December 1, 2023

Enrollment Period

6 months

First QC Date

March 14, 2023

Last Update Submit

December 11, 2023

Conditions

Keywords

Sleep restrictionGastrointestinal functionAppetite regulationGut hormonesHedonic appetite

Outcome Measures

Primary Outcomes (5)

  • Fasting blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine

    A fasting blood sample will be collected in EDTA and Heparin vacutainers in order to assess blood markers of appetite, gastrointestinal function and motivation to feed.

    Comparisons in fasting blood markers will be made between sleep restricted vs control conditions. A fasted blood sample will be collected during the 5 minute period from 08:10 - 08:15

  • Difference in postprandial blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine for a breakfast meal

    8 blood sample will be collected in EDTA and Heparin vacutainers in order to assess blood markers of appetite, gastrointestinal function and motivation to feed. Comparisons will be made between sleep restricted vs control conditions for the area under curve (AUC) for the 3 hour postprandial period.

    Following the ingestion of a breakfast meal at 08:15, blood will be drawn every 15 minutes until 1 hour postprandially, then every 30 minutes until 3 hours postprandially.

  • Difference in postprandial blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine for a lunch-time meal

    8 blood sample will be collected in EDTA and Heparin vacutainers in order to assess blood markers of appetite, gastrointestinal function and motivation to feed. Comparisons will be made between sleep restricted vs control conditions for the area under curve (AUC) for the 3 hour postprandial period.

    Following the ingestion of a lunchtime meal at 12:30, blood will be drawn every 15 minutes until 1 hour postprandially, then every 30 minutes until 3 hours postprandially.

  • Difference in postprandial blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine for an evening meal

    8 blood sample will be collected in EDTA and Heparin vacutainers in order to assess blood markers of appetite, gastrointestinal function and motivation to feed. Comparisons will be made between sleep restricted vs control conditions for the area under curve (AUC) for the 3 hour postprandial period.

    Following the ingestion of an evening meal meal at 16:45, blood will be drawn every 15 minutes until 1 hour postprandially, then every 30 minutes until 3 hours postprandially.

  • Difference in diurnal blood markers: Dopamine, Endocannabinoids, Ghrelin, Leptin, Orexin, and Peptide tyrosine tyrosine

    27 blood samples will be collected in EDTA and Heparin vacutainers throughout the day, in order to assess blood markers of appetite, gastrointestinal function and motivation to feed. Comparisons will be made between the area under curve (AUC) for the entire diurnal period (11.45 hours), for the sleep restricted vs control conditions.

    Blood samples will be drawn at 08:10, and continue to be drawn at regular intervals of 15, 30 and 60 minutes until 20:00.

Secondary Outcomes (16)

  • Difference in gastric emptying of an evening meal

    Every 15 mins for 2 hours following test meal. Comparisons will be made between sleep restricted and control conditions.

  • Difference in subjective feelings of appetite in a fasted state

    Ratings of fasting subjective appetite will be collected during the 5 minute period elapsed from 08:10 - 08:15. Comparisons will be made between sleep restricted vs control conditions.

  • Difference in subjective feelings of appetite following a breakfast meal

    Every 30 minutes up until 3 hours postprandially, following the ingestion of the test meal at 08:15.

  • Difference in subjective feelings of appetite following a lunch time meal

    Every 30 minutes up until 3 hours postprandially, following the ingestion of the test meal at 12:30.

  • Difference in subjective feelings of appetite following an evening meal

    Every 30 minutes up until 3 hours postprandially, following the ingestion of the test meal at 16:45

  • +11 more secondary outcomes

Study Arms (2)

Restricted sleep on blood markers and subjective markers of homeostatic, and hedonic appetite

EXPERIMENTAL

The proposed study will take the form of a within-subjects, randomized crossover experimental design. The data will be quantitative. The study will take place for total of approximately 5 weeks / 37 days (+ up to 6 weeks depending on their schedule: Minimum duration = 5 weeks (37 days), Maximum duration = Approximately 11 weeks (79 days).

Other: Sleep restriction

Restricted sleep on gastric emptying

EXPERIMENTAL

The proposed study will take the form of a within-subjects, randomized crossover experimental design. The data will be quantitative. The study will take place for total of approximately 5 weeks / 37 days (+ up to 6 weeks depending on their schedule: Minimum duration = 5 weeks (37 days), Maximum duration = Approximately 11 weeks (79 days).

Other: Sleep restriction

Interventions

The proposed study will take the form of a within-subjects, randomized crossover experimental design. The data will be quantitative.

Restricted sleep on blood markers and subjective markers of homeostatic, and hedonic appetiteRestricted sleep on gastric emptying

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy (As assessed with medical screening questionnaire)
  • Self-reported habitual bedtimes between 7 to 9 hours (As assessed with the Pittsburgh sleep quality index)
  • Between the ages of 18 to 45

You may not qualify if:

  • Participants will also be excluded from participation if they are pregnant.
  • Current smokers
  • Excessive alcohol (\>2 drinks per day)
  • Excessive caffeine (\>300mg per day)
  • Musculoskeletal injury.
  • Shift work during the past 4 weeks
  • Travel across more than one time zones during the past 4 weeks.
  • An indication of having a depressed mood (As assessed by a score on the Centre for Epidemiologic Studies of Depression scale above 16).
  • Moderately or highly physically active, as determined by the International Physical Activity Questionnaire (IPAQ) short form.
  • Excessive daytime sleepiness as measured by the Epworth Sleepiness Scale (Score \> 10) (ESS) (Hart et al., 2015).
  • Participants will also be considered ineligible if they achieve a score indicative of narcolepsy or chronic insomnia, as assessed through the Pittsburgh Sleep Quality Index \[PSQI\] (Score \> 5) (Hart et al., 2015).
  • Participants must achieve a score \< 50 on the Food Craving Questionnaire-Trait-reduced (FCQ-T-r), which has been shown to discriminated between individuals with and without "food addiction" with high sensitivity (85%) and specificity (93%) (Meule et al., 2014).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northumbria university

Newcastle upon Tyne, Tyne and Wear, NE3 1YF, United Kingdom

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The study is a within-subjects, randomized crossover experimental design.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2023

First Posted

July 20, 2023

Study Start

July 15, 2023

Primary Completion

January 17, 2024

Study Completion

January 17, 2024

Last Updated

December 15, 2023

Record last verified: 2023-12

Locations